To investigate the molecular mechanisms leading to AKT activation in Italian patients affected by NSCLC we performed a comprehensive analysis of the expression and/or the genetic status of AKT1 and AKT2 and their closest regulators (KRAS, PIK3CA and PTEN). The gene discussed is PTEN; the disease is non-small cell lung carcinoma.